[Cancer, hemostasis and coaguloactive drugs].
Nadiradze
I Sh
ISh
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006487:Hemostasis; D006801:Humans; D051379:Mice; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D009374:Neoplasms, Experimental / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D009360:Neoplastic Cells, Circulating; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011817:Rabbits
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors
Rak, gemostaz i koaguloaktivnye preparaty.